ZIRALIMUMAB
UNII M87C8Y2GMN

Substance Identification & Data

This profile provides standardized clinical and technical data for Ziralimumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) M87C8Y2GMN.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1427008-29-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

M87C8Y2GMN

CAS Registry Number

1427008-29-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ZIRALIMUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C188597

National Cancer Institute reference terminology for clinical and research data.

INN ID

8061

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ziralimumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.